These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study. Ali S; Borin TF; Piranlioglu R; Ara R; Lebedyeva I; Angara K; Achyut BR; Arbab AS; Rashid MH PLoS One; 2021; 16(2):e0246646. PubMed ID: 33544755 [TBL] [Abstract][Full Text] [Related]
7. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide. López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736 [TBL] [Abstract][Full Text] [Related]
8. The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors. Musca B; Russo MG; Tushe A; Magri S; Battaggia G; Pinton L; Bonaudo C; Della Puppa A; Mandruzzato S Front Immunol; 2023; 14():1236824. PubMed ID: 37936683 [TBL] [Abstract][Full Text] [Related]
9. Inhalant cannabidiol impedes tumor growth through decreased tumor stemness and impaired angiogenic switch in NCI-H1437-induced human lung cancer model. Salles ÉL; Naeini SE; Khodadadi H; Bhandari B; Rezaee S; Threlkeld E; Rogers HM; Costigliola V; Terry AV; Hess DC; Deb S; Deb SP; Yeudall WA; Yu JC; Wang LP; Baban B Hum Cell; 2023 May; 36(3):1204-1210. PubMed ID: 36737540 [TBL] [Abstract][Full Text] [Related]
10. Autophagy in glioblastoma: A mechanistic perspective. Meena D; Jha S Int J Cancer; 2024 Aug; 155(4):605-617. PubMed ID: 38716809 [TBL] [Abstract][Full Text] [Related]
11. The N Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G Front Immunol; 2021; 12():653711. PubMed ID: 34354698 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma. Han Y; Zou C; Liu T; Cheng W; Cheng P; Wu A J Exp Clin Cancer Res; 2024 Jul; 43(1):212. PubMed ID: 39085878 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics. Ye Z; Ai X; Zhao L; Fei F; Wang P; Zhou S Oncogene; 2021 Oct; 40(42):6059-6070. PubMed ID: 34556813 [TBL] [Abstract][Full Text] [Related]
14. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Nabissi M; Morelli MB; Santoni M; Santoni G Carcinogenesis; 2013 Jan; 34(1):48-57. PubMed ID: 23079154 [TBL] [Abstract][Full Text] [Related]
15. Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment. Mu Y; Zhang Z; Zhou H; Ma L; Wang DA Biomater Sci; 2024 Aug; 12(16):4045-4064. PubMed ID: 38993162 [TBL] [Abstract][Full Text] [Related]
16. Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy. White K; Connor K; Meylan M; Bougoüin A; Salvucci M; Bielle F; O'Farrell AC; Sweeney K; Weng L; Bergers G; Dicker P; Ashley DM; Lipp ES; Low JT; Zhao J; Wen P; Prins R; Verreault M; Idbaih A; Biswas A; Prehn JHM; Lambrechts D; Arijs I; Lodi F; Dilcan G; Lamfers M; Leenstra S; Fabro F; Ntafoulis I; Kros JM; Cryan J; Brett F; Quissac E; Beausang A; MacNally S; O'Halloran P; Clerkin J; Bacon O; Kremer A; Chi Yen RT; Varn FS; Verhaak RGW; Sautès-Fridman C; Fridman WH; Byrne AT Ann Oncol; 2023 Mar; 34(3):300-314. PubMed ID: 36494005 [TBL] [Abstract][Full Text] [Related]
18. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064 [TBL] [Abstract][Full Text] [Related]
19. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities. Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L Front Immunol; 2022; 13():964898. PubMed ID: 35967394 [TBL] [Abstract][Full Text] [Related]
20. Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments. Achyut BR; Shankar A; Iskander AS; Ara R; Knight RA; Scicli AG; Arbab AS Cancer Biol Ther; 2016; 17(3):280-90. PubMed ID: 26797476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]